AU2003289016A1 - Method of distinguishing drug-resistance of hepatitis b virus - Google Patents

Method of distinguishing drug-resistance of hepatitis b virus

Info

Publication number
AU2003289016A1
AU2003289016A1 AU2003289016A AU2003289016A AU2003289016A1 AU 2003289016 A1 AU2003289016 A1 AU 2003289016A1 AU 2003289016 A AU2003289016 A AU 2003289016A AU 2003289016 A AU2003289016 A AU 2003289016A AU 2003289016 A1 AU2003289016 A1 AU 2003289016A1
Authority
AU
Australia
Prior art keywords
hepatitis
virus
resistance
distinguishing drug
distinguishing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003289016A
Inventor
Kendo Kiyosawa
Akihiro Matsumoto
Akinori Rokuhara
Eiji Tanaka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Advanced Life Science Institute Inc
Original Assignee
Advanced Life Science Institute Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Life Science Institute Inc filed Critical Advanced Life Science Institute Inc
Publication of AU2003289016A1 publication Critical patent/AU2003289016A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003289016A 2002-12-11 2003-12-10 Method of distinguishing drug-resistance of hepatitis b virus Abandoned AU2003289016A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002359372 2002-12-11
JP2002-359372 2002-12-11
PCT/JP2003/015810 WO2004053162A1 (en) 2002-12-11 2003-12-10 Method of distinguishing drug-resistance of hepatitis b virus

Publications (1)

Publication Number Publication Date
AU2003289016A1 true AU2003289016A1 (en) 2004-06-30

Family

ID=32500935

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003289016A Abandoned AU2003289016A1 (en) 2002-12-11 2003-12-10 Method of distinguishing drug-resistance of hepatitis b virus

Country Status (5)

Country Link
JP (1) JP4398379B2 (en)
KR (1) KR20050095584A (en)
CN (1) CN100422343C (en)
AU (1) AU2003289016A1 (en)
WO (1) WO2004053162A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101177715B (en) * 2006-11-09 2010-12-29 中山大学达安基因股份有限公司 Method and reagent case for detecting hepatitis b virus anterior C/BCP region gene mutation
US8435764B2 (en) * 2009-05-06 2013-05-07 The Chinese University Of Hongkong Multiplex detection of hepatitis virus variations
CN101812537B (en) * 2009-10-27 2012-08-08 重庆医科大学 Method and reagent kit for simultaneously detecting resistance site of three nucleotide analogues of hepatitis B virus
CN101948834B (en) * 2010-09-16 2012-07-04 山东大学 siRNA for treating HBV
JP7455336B2 (en) * 2019-03-26 2024-03-26 富士フイルム株式会社 Pharmaceutical composition and screening method for inhibiting hepatitis B virus protein production

Also Published As

Publication number Publication date
JP4398379B2 (en) 2010-01-13
KR20050095584A (en) 2005-09-29
CN100422343C (en) 2008-10-01
WO2004053162A1 (en) 2004-06-24
CN1726287A (en) 2006-01-25
JPWO2004053162A1 (en) 2006-04-13

Similar Documents

Publication Publication Date Title
HK1070287A1 (en) Hepatitis c virus inhibitors
AU2003221157A1 (en) Method of judging viral infection
AU2002210450A1 (en) Maintaining virus detection software
AU2003286298A1 (en) Method of securing software updates
AU2003208921A1 (en) Emitter and method of making
AU2003206862A1 (en) Hepatitis b vaccines
AU2003216523A1 (en) Treatment of pre-core hepatitis b virus mutant infections
AU2003205169A1 (en) Viral vaccine production method
AU2003289016A1 (en) Method of distinguishing drug-resistance of hepatitis b virus
AU2001269092A1 (en) Inhibitors of hepatitis b virus infection
AU2002257890A1 (en) Method for replicating the hepatitis C virus
AU2002235940A1 (en) Method for the amplification and detection of hbv dna using a transcription based amplification
AU2003301865A1 (en) Epitopes of hepatitis c virus
AU2002952817A0 (en) Method for the detection of newly acquired hiv infection
AU2003256404A1 (en) Hepatitis c virus assays
AU2003230790A1 (en) Hepatitis c virus sub-genomic replicons
AU2003251356A1 (en) Viral marker
AU2001254670A1 (en) Detection of hepatitis b virus rna
AU2003266243A1 (en) 1-carbonyl-4-cyano-pyrrolidine-2-carboxylic acid derivatives as hepatitis c virus inhibitors
AU2003225479A1 (en) Reporter-selectable hepatitis c virus replicon
AU2001282560A1 (en) Methods of infection with hepatitis c virus
AU2003214299A1 (en) Hiv-1 virus tat-protein mutants
AU2002351795A1 (en) Hepatitis x virus antigen
AU2006233207A1 (en) Hepatitis C virus inhibitors
AU2002350322A1 (en) Inhibitors of hepatitis c virus protease

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase